Author: Matt Williams; Kerlann Le Calvez; Ella Mi; Jiarong Chen; Seema Dadhania; Lillie Pakzad-Shahabi
Title: Estimating the Risks from COVID-19 Infection in Adult Chemotherapy Patients Document date: 2020_3_20
ID: mlwrfkm4_18
Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . Figure 2 . Scenarios exploring absolute survival benefit and potential risks in a variety of common chemotherapy settings [15] [16] [17] [18] [19] [20] [21] [22] [23] cancer, or receiving chemotherapy is of secondary importance. If it is due to having cancer, then we would suggest that receiving chemotherapy would simple increase in further. We would stress that any add.....
Document: is the (which was not peer-reviewed) The copyright holder for this preprint . Figure 2 . Scenarios exploring absolute survival benefit and potential risks in a variety of common chemotherapy settings [15] [16] [17] [18] [19] [20] [21] [22] [23] cancer, or receiving chemotherapy is of secondary importance. If it is due to having cancer, then we would suggest that receiving chemotherapy would simple increase in further. We would stress that any additional risk from administering chemotherapy is likely to be a multiplier on the risks seen here; thus small relative risks may translate to large changes in absolute risk for some patients. We have also assumed that both harm and benefits accrue over the same time period, whereas in reality, most improvements in cancer survival with chemotherapy are calculated at 2 and 5 years. For patients undergoing palliative chemotherapy, it is probably more reasonable to assume that the risks and harms accrue over a similar time period; for those having adjuvant treatment, where chemotherapy increases the chance of cure, the benefits may accrue over a much longer time period. In this sense, treatment is more valuable (in that it leads to more years of life) but harm from treatment also weighs more heavily.
Search related documents:
Co phrase search for related documents- absolute risk and adjuvant treatment: 1
- absolute risk and benefit harm: 1, 2, 3, 4, 5
- absolute risk and chemotherapy setting: 1
- absolute risk and harm risk: 1, 2, 3, 4, 5
- additional risk and adjuvant treatment: 1, 2, 3
- additional risk and benefit harm: 1
- additional risk and chemotherapy setting: 1
- additional risk and harm risk: 1, 2, 3, 4
- adjuvant treatment and cancer survival: 1, 2, 3, 4, 5, 6
- adjuvant treatment and chemotherapy receive: 1, 2, 3
- adjuvant treatment and chemotherapy setting: 1
- benefit harm and harm risk: 1, 2, 3, 4, 5, 6, 7
- cancer survival and chemotherapy cancer survival improvement: 1
- cancer survival and chemotherapy receive: 1, 2, 3
- cancer survival and chemotherapy setting: 1, 2
- cancer survival improvement and chemotherapy cancer survival improvement: 1
- cancer survival improvement and chemotherapy receive: 1
- chemotherapy receive and cure chance: 1
Co phrase search for related documents, hyperlinks ordered by date